Company HansBiomed Corporation

Equities

A042520

KR7042520007

Medical Equipment, Supplies & Distribution

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Holdings

Company contact information

Sector

Sales per Business

Sales per region

Quarterly revenue - Rate of surprise

Sector Medical Devices & Implants

End-of-day quote Korea S.E. Other stock markets 23:00:00 13/05/2024 BST			5-day change	1st Jan Change
13,490 ^KRW	+7.06%		+2.98%	-8.11%

02-14	HansBiomed Corporation Reports Earnings Results for the First Quarter Ended December 31, 2023	CI
2023	HansBiomed Corporation(KOSDAQ:A042520) added to S&P Global BMI Index	CI

HansBiomed Co.,Ltd is a Korea-based company engaged in the biotechnology industry. The Company mainly provides three categories of products: skin-implant materials, bone-implant materials and silicone products. Its skin-implant materials are used for burn treatment and skin graft under the brand names of SureDerm, BellaGen and GPS. Its bone-implant materials include allogeneic bones, xenogenous bones and synthetic bones used in dentistry, orthopedic and others, which are under the brand names of SureFuse, ExFuse and SureOss. Its silicone products are used for treatments of scars and for breast implant and others, which are under the brand names of BellaGel and Scar Clinic. In addition, it provides hair transplanters and others.

Number of employees: 254

KRW in Million	2022	Weight	2023	Weight	Delta
Medical Devices 47.9 %	39,192	52.6 %	37,408	47.9 %	-4.55%
Human Tissue 47.7 %	32,292	43.4 %	37,201	47.7 %	+15.20%
Other 4.4 %	2,975	4.0 %	3,423	4.4 %	+15.04%

KRW in Million	2022	Weight	2023	Weight	Delta
South Korea 52.6 %	34,720	46.6 %	41,052	52.6 %	+18.24%
North America 25.4 %	22,768	30.6 %	19,855	25.4 %	-12.79%
Asia 11.2 %	9,140	12.3 %	8,732	11.2 %	-4.46%
South America 6.9 %	4,185	5.6 %	5,410	6.9 %	+29.28%
Europe 2.9 %	2,899	3.9 %	2,260	2.9 %	-22.03%
Others 0.9 %	747	1.0 %	722	0.9 %	-3.44%

Managers	Title	Age	Since
Geun-Young Kim CEO	Chief Executive Officer	60	-
Ho-Chan Hwang BRD	Director/Board Member	65	-
Chang-Hee Kim AUD	Comptroller/Controller/Auditor	58	05/12/17

Members of the board	Title	Age	Since
Ho-Chan Hwang BRD	Director/Board Member	65	-
Geun-Young Kim CEO	Chief Executive Officer	60	-
Sang-Seok Oh BRD	Director/Board Member	54	25/12/19
Jung-Bin Lee BRD	Director/Board Member	36	-

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	13,526,367	8,168,830 ( 60.39 %)	539,388 ( 3.988 %)	60.39 %

Name	Equities	%	Valuation
Ho-Chan Hwang 23.95 %	3,240,147	23.95 %	31 M ₩
OSSTEM IMPLANT CO., LTD. 10.42 %	1,409,159	10.42 %	13 M ₩
HANSBIOMED CORPORATION 3.988 %	539,388	3.988 %	5 M ₩
Kyoo-Ok Choi 1.316 %	178,000	1.316 %	2 M ₩
Deok-goo Hwang 0.9036 %	122,220	0.9036 %	1 M ₩
Geun-Young Kim 0.3327 %	45,000	0.3327 %	429 129 ₩
DFA Australia Ltd. 0.005197 %	703	0.005197 %	6 704 ₩

Name	Equities	%	Valuation
HANSBIOMED CORPORATION 3.99%	539,388	3.99%	5,143,717 $

Hans Biomed Corp.

7 Jeongui-ro 8-gil Songpa-gu

05836, Seoul

http://www.hansbiomed.com

Company calendar

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Medical Equipment, Supplies & Distribution

Medical Devices & Implants

	1st Jan change	Capi.
HANSBIOMED CORPORATION	-8.11%	128M
STRYKER CORPORATION	+8.29%	124B
SMITH & NEPHEW PLC	-5.61%	11.17B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	+4.83%	9.17B
GLAUKOS CORPORATION	+39.60%	5.59B
INSPIRE MEDICAL SYSTEMS, INC.	-22.04%	4.71B
AXONICS, INC.	+8.39%	3.44B
ENOVIS CORPORATION	-6.28%	2.88B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	-10.23%	2.11B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	-5.99%	2.09B

Medical Devices & Implants